Non-small cell lung cancer
Conditions
Interventions
treatment group:TCM syndrome differentiation treatment
Control group:no intervention, observation only
Sponsors
Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: pathology-confirmed diagnosis of primary NSCLC, completely resected stage IIIA disease; completed 4 cycles of adjuvant chemotherapy (IIIA-N2 patients can receive postoperative adjuvant radiotherapy) within 1 month without recurrence or metastasis; no Chinese medicine treatment during postoperative adjuvant therapy; TCM syndromes of Qi deficiency, Yin deficiency, or Qi and Yin deficiency; aged 18–75 years; Eastern Cooperative Oncology Group (ECOG) PS score of =3; voluntarily involved in the clinical study and signed informed consent.
Exclusion criteria
Exclusion criteria: no clear pathological diagnosis; expected lifetime < 6 months; serious heart, liver, kidney or hematopoietic conditions with severe dysfunction; being pregnant or breast-feeding; mental or cognitive disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1-year disease-free survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| CD4+CD25+Foxp3+Treg cells and their functional phenotypes CD39 and CTLA-4;Disease free survival;Quality of Life; | — |
Countries
China
Contacts
Public ContactJiang Yi
Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Outcome results
None listed